Inicio › Enfermedades autoinmunes › Illinois
Ensayos clínicos de Enfermedades autoinmunes en Illinois
17 estudios sobre Enfermedades autoinmunes buscan participantes en Illinois.
Ciudades en Illinois
Texto oficial del estudio (inglés)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1054, Schaumburg
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
- Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
- The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago
ReclutandoFase 2/3
Edades de 6 a 75 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Chicago, Department of Medicine: Rheumatology, Chicago
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07103746Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Willow Rheumatology Wellness, Willowbrook
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07621809Study of PTC844 in Participants With Active Rheumatoid Arthritis
- Chicago Arthritis and Regenerative Medicine, Chicago
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07779616A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- The University of Chicago Medical Center, Chicago
ReclutandoFase 1
Edades de 18 a 74 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07085104Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
- Site 105, Orland Park
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT07885605Testimonials and Navigation in Rheumatology
- Northwestern University, Evanston
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT06469788RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Northwestern Memorial Hospital, Chicago
ReclutandoFase 1/2
Edades de 18 a 70 · Todos los sexos · Actualizado el 19 oct 2026 · NCT06359041RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT06328777A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- Northwestern University, Chicago
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT04422912RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center - Accepting Adult and Adolescent Patients, Chicago
ReclutandoFase 1/2
Edades de 12 a 65 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06121297A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- University of Chicago, Chicago
ReclutandoFase 2
Edades de 16 a 70 · Todos los sexos · Actualizado el 17 sept 2026 · NCT07328581A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- University of Illinois Hospital & Health Sciences System, Chicago
ReclutandoFase 1/2
Edades de 35 a 70 · Todos los sexos · Actualizado el 21 ago 2026 · NCT06575426A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- y 3 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Northwestern University, Chicago
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 30 jun 2026 · NCT06201416The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- University of Chicago Medical Center, Chicago
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 mar 2026 · NCT01280825De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.